ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VKTX Viking Therapeutics Inc

64.47
1.05 (1.66%)
Apr 22 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Viking Therapeutics Inc VKTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.05 1.66% 64.47 20:00:00
Open Price Low Price High Price Close Price Prev Close
63.96 62.30 64.94 63.85 63.42
more quote information »

Recent News

Date Time Source Heading
4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
4/17/202416:05PRNUSViking Therapeutics to Report Financial Results for First..
3/26/202407:03PRNUSViking Therapeutics Announces Results from Phase 1 Clinical..
3/04/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:52EDGAR2Form 8-K - Current report
3/04/202416:45PRNUSViking Therapeutics Announces Closing of Public Offering of..
3/01/202416:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/28/202420:50PRNUSViking Therapeutics Announces Pricing of $550 Million Public..
2/27/202417:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/27/202416:19PRNUSViking Therapeutics Announces Proposed Public Offering of..
2/27/202407:04EDGAR2Form 8-K - Current report
2/27/202407:03PRNUSViking Therapeutics Announces Positive Top-Line Results from..
2/09/202420:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202416:01EDGAR2Form 144 - Report of proposed sale of securities
2/08/202419:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202419:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:56EDGAR2Form 144 - Report of proposed sale of securities
2/08/202416:33EDGAR2Form 144 - Report of proposed sale of securities
2/07/202417:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/07/202417:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/07/202416:09EDGAR2Form 8-K - Current report
2/07/202416:05PRNUSViking Therapeutics Reports Fourth Quarter and Year-End 2023..
1/31/202420:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:32EDGAR2Form 144 - Report of proposed sale of securities
1/31/202416:05PRNUSViking Therapeutics to Report Financial Results for Fourth..
1/30/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202416:23EDGAR2Form 144 - Report of proposed sale of securities
1/19/202420:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202416:36EDGAR2Form 144 - Report of proposed sale of securities
1/04/202421:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202421:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202421:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202316:02PRNUSViking Therapeutics Presents New Data from Phase 2b VOYAGE..
11/02/202316:03PRNUSViking Therapeutics to Participate at Upcoming Investor..
10/25/202317:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/25/202316:24EDGAR2Form 8-K - Current report
10/25/202316:05PRNUSViking Therapeutics Reports Third Quarter 2023 Financial..
10/23/202307:05PRNUSViking Therapeutics Announces Completion of Enrollment in..
10/18/202316:05PRNUSViking Therapeutics to Report Financial Results for Third..
10/18/202309:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
10/18/202309:03IHMARKETNEWSWednesday’s Wall Street Highlights: ASML, Nvidia, United..
10/17/202316:05PRNUSViking Therapeutics Presents New Data from Phase 1 Clinical..
10/10/202316:05PRNUSViking Therapeutics to Highlight Data from Phase 1 Clinical..
9/07/202316:05PRNUSViking Therapeutics to Participate at Upcoming Investor..
9/06/202307:03PRNUSViking Therapeutics Announces Initiation of Phase 2 VENTURE..
7/26/202317:26EDGAR2Form S-3ASR - Automatic shelf registration statement of..
7/26/202316:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/26/202316:23EDGAR2Form 8-K - Current report
7/26/202316:05PRNUSViking Therapeutics Reports Second Quarter 2023 Financial..
7/19/202316:05PRNUSViking Therapeutics to Report Financial Results for Second..

Your Recent History

Delayed Upgrade Clock